Search Results - "Lentine, K. L."

Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression by Pinsky, B. W., Takemoto, S. K., Lentine, K. L., Burroughs, T. E., Schnitzler, M. A., Salvalaggio, P. R.

“…We describe factors associated with immunosuppression compliance after kidney transplantation and examine relationships between compliance with allograft…”
Get full text

MELD Exceptions and Rates of Waiting List Outcomes by Massie, A. B., Caffo, B., Gentry, S. E., Hall, E. C., Axelrod, D. A., Lentine, K. L., Schnitzler, M. A., Gheorghian, A., Salvalaggio, P. R., Segev, D. L.

“…Model for End‐stage Liver Disease (MELD)‐based allocation of deceased donor livers allows exceptions for patients whose score may not reflect their true…”
Get full text

Addressing Geographic Disparities in Liver Transplantation Through Redistricting by Gentry, S. E., Massie, A. B., Cheek, S. W., Lentine, K. L., Chow, E. H., Wickliffe, C. E., Dzebashvili, N., Salvalaggio, P. R., Schnitzler, M. A., Axelrod, D. A., Segev, D. L.

“…Severe geographic disparities exist in liver transplantation; for patients with comparable disease severity, 90‐day transplant rates range from 18% to 86% and…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

A Retrospective Analysis of Immunosuppression Compliance, Dose Reduction and Discontinuation in Kidney Transplant Recipients by Takemoto, S. K., Pinsky, B. W., Schnitzler, M. A., Lentine, K. L., Willoughby, L. M., Burroughs, T. E., Bunnapradist, S.

“…We describe factors associated with poor compliance and dose reductions and examine the relative impact of compliance, dose reduction and discontinuation on…”
Get full text

Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data by Vest, L. S., Koraishy, F. M., Zhang, Z., Lam, N. N., Schnitzler, M. A., Dharnidharka, V. R., Axelrod, D., Naik, A. S., Alhamad, T. A., Kasiske, B. L., Hess, G. P., Lentine, K. L.

“…While guidelines support metformin as a therapeutic option for diabetic patients with mild‐to‐moderate renal insufficiency, the frequency and outcomes of…”
Get full text

OPTN/SRTR 2020 Annual Data Report: Kidney by Lentine, K. L., Smith, J. M., Hart, A., Miller, J., Skeans, M. A., Larkin, L., Robinson, A, Gauntt, K., Israni, A. K., Hirose, R., Snyder, J. J.

“…The year 2020 presented significant challenges to the field of kidney transplantation. After increasing each year since 2015 and reaching the highest annual…”
Get full text

Risk of Kidney Stones With Surgical Intervention in Living Kidney Donors by Thomas, S. M., Lam, N. N., Welk, B. K., Nguan, C., Huang, A., Nash, D. M., Prasad, G. V. R., Knoll, G. A., Koval, J. J., Lentine, K. L., Kim, S. J., Lok, C. E., Garg, A. X.

“…A kidney stone in a person with a solitary kidney requires urgent attention, which may result in surgical and/or hospital attention. We conducted a matched…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Kidney by Hart, A., Lentine, K. L., Smith, J. M., Miller, J. M., Skeans, M. A., Prentice, M., Robinson, A., Foutz, J., Booker, S. E., Israni, A. K., Hirose, R., Snyder, J. J.

“…Despite the ongoing severe shortage of available kidney grafts relative to candidates in need, data from 2019 reveal some promising trends. After remaining…”
Get full text

The Economic Implications of Broader Sharing of Liver Allografts by Axelrod, D. A., Gheorghian, A., Schnitzler, M. A., Dzebisashvili, N., Salvalaggio, P. R., Tuttle‐Newhall, J., Segev, D. L., Gentry, S., Hohmann, S., Merion, R. M., Lentine, K. L.

“…Liver transplantation has evolved over the past four decades into the most effective method to treat end‐stage liver failure and one of the most expensive…”
Get full text

Association of Lower Costs of Pulsatile Machine Perfusion in Renal Transplantation from Expanded Criteria Donors by Buchanan, P. M., Lentine, K. L., Burroughs, T. E., Schnitzler, M. A., Salvalaggio, P. R.

“…Pulsatile machine perfusion (PMP) has been shown to reduce delayed graft function (DGF) in expanded criteria donor (ECD) kidneys. Here, we investigate whether…”
Get full text

Income‐Related Disparities in Kidney Transplant Graft Failures Are Eliminated by Medicare's Immunosuppression Coverage by Woodward, R. S., Page, T. F., Soares, R., Schnitzler, M. A., Lentine, K. L., Brennan, D. C.

“…Beginning January 1, 2000, Medicare extended coverage of immunosuppression medications from 3 years to lifetime based on age >65 years or disability. Using…”
Get full text

Patient and Graft Survival Implications of Simultaneous Pancreas Kidney Transplantation From Old Donors by Salvalaggio, P. R., Schnitzler, M. A., Abbott, K. C., Brennan, D. C., Irish, W., Takemoto, S. K., Axelrod, D., Santos, L. S., Kocak, B., Willoughby, L., Lentine, K. L.

“…We investigated graft and patient survival implications of simultaneous pancreas kidney (SPK) transplant from old donors. Data describing patients with type 1…”
Get full text

Predictive Ability of Pretransplant Comorbidities to Predict Long‐Term Graft Loss and Death by Machnicki, G., Pinsky, B., Takemoto, S., Balshaw, R., Salvalaggio, P. R., Buchanan, P. M., Irish, W., Bunnapradist, S., Lentine, K. L., Burroughs, T. E., Brennan, D. C., Schnitzler, M. A.

“…Whether to include additional comorbidities beyond diabetes in future kidney allocation schemes is controversial. We investigated the predictive ability of…”
Get full text

The Clinical Importance of Flow Cytometry Crossmatch in the Context of CDC Crossmatch Results by Graff, R.J, Buchanan, P.M, Dzebisashvili, N, Schnitzler, M.A, Tuttle-Newhall, J, Xiao, H, Schadde, E, Gheorghian, A, Lentine, K.L

“…Abstract Background The complement-dependent microcytotoxicity crossmatch (CDCXM) is a standard method for evaluating the presence of preformed antibodies…”
Get full text

Perioperative Complications After Living Kidney Donation: A National Study by Lentine, K. L., Lam, N. N., Axelrod, D., Schnitzler, M. A., Garg, A. X., Xiao, H., Dzebisashvili, N., Schold, J. D., Brennan, D. C., Randall, H., King, E. A., Segev, D. L.

“…We integrated the US transplant registry with administrative records from an academic hospital consortium (97 centers, 2008–2012) to identify predonation…”
Get full text

Patterns of End‐Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors by Anjum, S., Muzaale, A. D., Massie, A. B., Bae, S., Luo, X., Grams, M. E., Lentine, K. L., Garg, A. X., Segev, D. L.

“…Inferences about late risk of end‐stage renal disease (ESRD) in live kidney donors have been extrapolated from studies averaging <10 years of follow‐up…”
Get full text

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

“…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
Get full text

The National Landscape of Living Kidney Donor Follow‐Up in the United States by Henderson, M. L., Thomas, A. G., Shaffer, A., Massie, A. B., Luo, X., Holscher, C. M., Purnell, T. S., Lentine, K. L., Segev, D. L.

“…In 2013, the Organ Procurement and Transplantation Network (OPTN)/ United Network for Organ Sharing (UNOS) mandated that transplant centers collect data on…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per‐person…”
Get full text